Amgros 2027 2.206.A Tender in Denmark - 147502076

Procurement Summary

Country: Denmark

Summary: Amgros 2027 2.206.A

Deadline: 08 Oct 2026

Posting Date: 19 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147502076

Document Ref. No.:

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Subcontract: LOT-0001 Title: Tender number 1 Description: Amgros I/S (Amgros) is a partnership with the 5 regions as stakeholders. Amgros wishes to enter into framework agreements for the medicines that appear in the individual sub-contracts below, with a view to supply the hospital pharmacies of the stakeholders with medicines as well as possible resale to the Faroe Islands and Greenland. Amgros resells the medicines to the hospital pharmacies at Amgros' purchase price with a surcharge. The framework agreements are non-exclusive. The framework agreements are concluded without obligation to purchase, and the hospital pharmacies in the regions are not obliged to use Amgros' framework agreements. CPV code: Medicines [33600000]
Deadline: 2026-10-08 Place of execution: Denmark, City of Copenhagen (DK011) Description: The tender number (subcontract) includes the following drugs: ATC Code: H01BB02 · Generic name: Oxytocin · Dispensing form: Konc.inj.inf.vsk.opl · Strength: 5 IU/ml · Unit value: 15 U · Quantity in units: 999. Each tender number is considered an independent partial contract and is offered independently of the other tender numbers. A supplier can thus choose to make an offer for one, several or all tender numbers, and allocation is made separately for each tender number. A supplier can thus be awarded one, several or all partial contracts. Reference is made to the tender conditions, including the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, a estimated consumption of the medicines under the tender number, but the actual consumption may differ significantly from there. The suppliers must anticipate this. The background for this is that these are medicines for patient treatment in public hospitals, where the patient's needs must be met. For a more detailed description, please refer to the tender conditions and the framework agreement.

Documents

 Tender Notice